Nuveen
CRBU icon

Nuveen’s Caribou Biosciences CRBU Stock Holding History

Nuveen’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+123,516
New +$244K ﹤0.01% 3613
2025
Q2 		– Sell
-330,831
Closed -$302K – 3297
2025
Q1 		$302K Hold
330,831
– – ﹤0.01% 3043
2024
Q4 		$526K Buy
330,831
+63,096
+24% +$127K ﹤0.01% 2967
2024
Q3 		$525K Hold
267,735
– – ﹤0.01% 3002
2024
Q2 		$439K Hold
267,735
– – ﹤0.01% 3035
2024
Q1 		$1.38M Hold
267,735
– – ﹤0.01% 2564
2023
Q4 		$1.53M Buy
267,735
+18,695
+8% +$92.4K ﹤0.01% 2530
2023
Q3 		$1.19M Buy
249,040
+16,162
+7% +$100K ﹤0.01% 2505
2023
Q2 		$990K Sell
232,878
-60,086
-21% -$270K ﹤0.01% 2666
2023
Q1 		$1.56M Sell
292,964
-13,922
-5% -$86.7K ﹤0.01% 2435
2022
Q4 		$1.93M Buy
306,886
+83,479
+37% +$743K ﹤0.01% 2403
2022
Q3 		$2.36M Sell
223,407
-31,459
-12% -$293K ﹤0.01% 2317
2022
Q2 		$1.38M Buy
254,866
+62,686
+33% +$479K ﹤0.01% 2628
2022
Q1 		$1.76M Buy
192,180
+129,399
+206% +$1.36M ﹤0.01% 2560
2021
Q4 		$1.01M Sell
62,781
-3,007
-5% -$58.5K ﹤0.01% 2859
2021
Q3 		$1.57M Buy
+65,788
New +$1.61M ﹤0.01% 2788

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nuveen's CRBU Position: Q2 2026 in Review

Nuveen opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 123,516 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #3613 among its holdings. This is a return to the name: Nuveen previously reported a position in CRBU as recently as Q1 2025.

Nuveen first reported a position in CRBU in Q3 2021 and has held it in 16 quarters since. The position peaked at $2.36M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Nuveen held 123,516 shares of Caribou Biosciences worth $217K as of Q2 2026.
  • Caribou Biosciences was a new Nuveen position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3613 holding.
  • Nuveen first reported a position in Caribou Biosciences in Q3 2021 and has held it in 16 quarters since.
  • Nuveen's Caribou Biosciences position peaked at $2.36M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.